Alpha-1-syntrophin protein is differentially expressed in human cancers

Biomarkers

Volumn 16, Issue 1, 2011, Pages 31-36

  Bhat, Hina F ^a   Baba, Rafia A ^a   Bashir, Muneesa ^a   Saeed, Safder ^a   Kirmani, Deeba ^a   Wani, Mudassir M ^b   Wani, Nisar A ^b   Wani, Khursheed A ^c   Khanday, Firdous A ^a  

^a UNIVERSITY OF KASHMIR   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

^c Sheri Kashmir Institute of Medical Sciences   (India)

Author keywords

adenocarcinoma; Alpha 1 syntrophin; breast cancer; esophageal squamous cell carcinoma; signal transduction

Indexed keywords

ALPHA1 SYNTROPHIN; SYNTROPHIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; COLON CANCER; DOWN REGULATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PROTEIN EXPRESSION; RECTUM CANCER; STOMACH CANCER; UPREGULATION;

ADENOCARCINOMA; ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; NEOPLASMS; UP-REGULATION;

EID: 79251491074     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.522731     Document Type: Article

References (35)

1. Adams ME, Butler MH, Dwyer TM, Peters MF, Murnane AA, Froehner SC (1993). Two forms of mouse syntrophin, a 58 kD dystrophin-associated protein, difer in primary structure and tissue distribution. Neuron 11:531-40.
2. Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkel LM. (1996). Te three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal location, and each bind to dystrophin and its relatives. J Biol Chem 271: 2724-30.
3. Ahn AH, Yoshida M, Anderson MS, Freener CA, Selig S, Hagiwara Y Ozawa E, Kunkel LM. (1994). Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24. Proc Natl Acad Sci USA 91: 4446-50.
4. Angela H, Yury Y José C, Christopher O, Elias D, Kazuhiko M, Stephen HG. (2004). Te phosphoinositol 3, 4-bisphosphate-binding protein TAPP1 interacts with syntrophins and regulates actin cytoskeletal organization. J Biol Chem 279:53717-24.
5. Bashir M, Kirmani D, Bhat HF, Baba RA, Hamza R, Naqash S, Wani NA, Andrabi KI, Zargar MA, Khanday FA. (2010). P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers. Cell Commun Signal 8:13.
6. Campbell KP, Kahl SD. (1989). Association of dystrophin and an inte-gral membrane glycoprotein. Nature 338:259-62.
7. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI. (2008). Characterisation and protein expression profling of annexins in colorectal cancer. Br J Cancer 98:426-33.
8. Froehner SC (1984). Peripheral proteins of postsynaptic membranes from Torpedo electric organ identifed with monoclonal antibod-ies. J Cell Biol 99:88-96.
9. Gröne J, Weber B, Staub E, Heinze M, Klaman I, Pilarsky C, Hermann K, Castanos-Velez E, Röpcke S, Mann B. (2006). Diferential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1,-8 and-12. Int J Colorectal Dis 22:651-9.
10. Hofman EP, Brown RH, Kunkel LM. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-28.
11. Hirotsugu T, Yoshihiro K. (2006). Immunohistochemical analysis of p53 in colorectal cancer regarding clinic-pathological correlation and prognostic signifcance. J Surg Oncol 58:125-8.
12. Jackson JG, Yoneda T, Clark GM, Yee D. (2000). Elevated levels of p66shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Can Res 6:1135-9.
13. Kasuno K, Naqvi A, DeRicco J, Yamamori T, Santhanam L, Mattagajasingh I, Yang S, Meyskens FL, Bosserhof AK, Irani K. (2007). Antagonism of p66shc by melanoma inhibitory activity. Cell Death Diferentiation 14:1414-21.
14. Khanday FA, Santhanam L, Kasuno K, Yamamori T, Naqvi A, DeRicco J, Bugayenko A, Mattagajasingh I, Disanza A, Scita G, Irani K. (2006a). SOS-mediated activation of Rac1 by p66shc. J Cell Biol 172:817-22.
15. Khanday FA, Yamamori T, Singh IM, Zhang Z, Bugayenko A, Naqvi A, Santhanam L, Nabi N, Kasuno K, Day BW, Irani K. (2006b). Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in rac1-induced oxidative stress. Mol Biol Cell 17:122-9.
16. Kramarcy NR, Vidal A, Froehner SC, Sealock R. (1994). Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin). J Biol Chem 269:2870-6.
17. Ku TKS, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. (2007). Loss of p53 expression correlates with metastatic phenotype and transcriptional profle in a new mouse model of head and neck cancer. Mol Cancer Res 5:351-62.
18. Luo S, Chen Y Lai KO, Arévalo JC, Froehner SC, Adams ME, Chao MV, Ip NY (2005). α-1-syntrophin regulates ARMS localization at the neuromuscular junction and enhances EphA 4 signaling in an ARMS-dependent manner. J Cell Biol 169:813-24.
19. Miguel V, Amparo AP, Beatriz G. (2005). Binding of PTEN to specifc PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem 280:28936-43.
20. Montanaro F, Carbonetto S. (2003). Targeting dystroglycan in the brain. Neuron 37:193-6.
21. Oak SA, Russo K, Petrucci TC, and Jarrett HW. (2001). Mouse 1-syntrophin binding to grb2: further evidence of a role for syntrophin in cell signaling. Biochemistry 40:11270-8.
22. Oak SA, Zhou YW, Jarrett HW. (2003). Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1. J Biol Chem 278:39287-95.
23. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. (1993). Dystrophin protects the sarcolemma from stresses devel-oped during muscle contraction. Proc Natl Acad Sci USA 90: 3710-14.
24. Piluso G, Mirabella M, Ricci E, Belsito A, Abbondanza C,Servidei S, Puca AA,Tonali P, GA, Nigro V. (2000). γ 1-and γ 2-Syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J Biol Chem 275:15851-60.
25. Sahai E, Marshall CJ. (2002). Rho-GTPases and cancer. Nat Rev Cancer 2:133-42.
26. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. (1991). p53 in colorectal cancer: clinic-pathological correlation and prognostic signifcance. Br J Cancer 63:317-19.
27. Sheng M, Sala C. (2001). PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 24:1-29.
28. Subauste MC, Nalban P, Adamson ED, Hahn KM. (2005). Vinculin con-trols PTEN protein level by maintaining the interaction of the adherent junction protein β-catenin with the scafolding protein MAGI-2. J Biol Chem 280:5676-81.
29. Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR. (2001). Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276:48627-30.
30. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE. (2000a). Evidence for reg-ulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scafold protein MAGI-2. Proc Natl Acad Sci USA 97:4233-8.
31. Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA. (2000b). Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem 275:21477-85.
32. Yang B, Ibraghimov-Beskrovnaya O, Moomaw CR, Slaughter CA, Campbell KP. (1994). Heterogeneity of the 59-kDa dystrophin associated protein revealed by cDNA cloning and expression. J Biol Chem 269:6040-4.
33. Yan WZ, Daifeng J, Donald BT, Harry WJ. (2007). Laminin-induced acti-vation of Rac1 and JNKp46 is initiated by Src family kinases and mimics the efects of skeletal muscle contraction. Biochemistry 46:14907-16.
34. Yan WZ, Oak SA, Susan E, Senogles, Harry WJ. (2004). Laminin-{alpha} 1 globular domains 3 and 4 induce heterotrimeric G protein bind-ing to {alpha}-syntrophin's PDZ domain and alter intracellular Ca2+ in muscle. Am J Physiol Cell Physiol 288:377-88.
35. Yukimasa S, Masaki T, Yoshida S, Uchida N, Watanabe S, Usuki H, Yoshiji H, Maeta T, Ebara K, Nakatsu T (2005). Enhanced expres-sion of p46shc in the nucleus and p52shc in the cytoplasm of human gastric cancer. Int J Oncol 26:905-11.